Curcumin was first described in modern scientific literature in 1937 by Oppenheimer. Since then, it has been the subject of more than 4,000 scientific reports exploring its wide range of biological activities. Curcumin is recognized for its antioxidant properties and for supporting healthy inflammatory responses. These broad, multi-pathway actions often referred to as “pleiotropic effects” are related to the compound’s ability to interact with and influence multiple molecular targets within the body.
Hence, Curcumin, which has the ability to interact with several molecular targets, represents the term “polypharmacology” as a classical example that elucidates the concept of “one drug-multiple targets” rather than traditional concept of “one drug-one target”.
Curcumin exhibits its biological activities by direct binding and indirect modulation (upregulation or downregulation) of targets. These biological activities are influenced by its chemical structure—two phenyl groups connected by a methylene bridge that allows different conformations. Such flexible chemical structure bring about ability to Curcumin to modulate or interfere several biochemical pathways— a versatility towards broad-spectrum of targets.
Various molecular targets of curcumin include inflammatory molecules, enzymes, growth factors, transcription factors, kinases, receptors and metal ions.
Analysis of Chemical Structure vis-a-vis Biological Activity
As discussed earlier, because of its inherent chemical functionality—can exhibit several different conformations—directly binds to diverse proteins with high affinity. The moieties such as phenyl, hydroxyl, methoxyl and the 1,3-dicarbonyl functional groups offer a strong and directed electrostatic interaction helping enhanced favourable binding-free energies.
Furthermore, Curcumin displays additional chemical functionality as it undergoes the “keto-enol tautomerism” as a result of the β-diketone moiety. It has been observed that enol form— the predominant form allows the midsection of the molecule to act as both hydrogen bond donor and acceptor; it may also act as a chelator for positively charged metals present in the active sites of target proteins.
Reference: Majeed M. and Badmaev V. Curcuminoids-Pharmacological Actions Including Pre-Clinical and Clinical Evaluations. In: Curcuminoids: Antioxidant phytonutrients, New Jersey, Nutriscience Publishers Inc., 2003;pp. 32